Cargando...
Bevacizumab-Based Therapies in the First-Line Treatment of Metastatic Colorectal Cancer
Since its approval for the first-line treatment of metastatic colorectal cancer (mCRC), bevacizumab has become a standard treatment option in combination with chemotherapy for patients with mCRC. Bevacizumab has demonstrated efficacy in combination with a number of different backbone chemotherapy re...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
AlphaMed Press
2012
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3336830/ https://ncbi.nlm.nih.gov/pubmed/22477726 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0003 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|